BTIG Research has recently reduced BioNano Genomics Inc (BNGO) stock to Neutral rating, as announced on September 10, 2024, according to Finviz. Earlier, on January 5, 2023, Scotiabank had initiated ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.52% of ...

BTIG downgrades shares of Bionano Genomics (NASDAQ:BNGO) from Buy to Neutral following news that the company has announced ...

Fintel reports that on September 10, 2024, BTIG downgraded their outlook for Bionano Genomics (NasdaqCM:BNGO) from Buy to ...

Bionano Genomics, Inc. (NASDAQ: BNGO) shares are trading lower Monday. The company's stock began trading on a reverse split-adjusted basis on Monday. Erica Kollmann Over $1M Bet On Bioventus?

Short interest in Bionano Genomics Inc (NASDAQ:BNGO) decreased during the last reporting ... are betting on the decline of Bionano Genomics's stock. Short interest data is updated every two ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

BioNano Genomics (BNGO – Research Report) received a Hold rating and price target from BTIG analyst Mark Massaro today. The ...

Turning to the Wall Street community sees the stock as a Buy, just 2 analysts gave BNGO a Strong Buy while 0 were with Buy whereas, 2 of them gave the stock a Hold recommendation, and none were on ...